Core Viewpoint - Plexus reported strong Q3 fiscal 2025 earnings, with adjusted EPS of $1.90, surpassing estimates and showing significant year-over-year growth [3][15]. Financial Performance - Q3 adjusted EPS was $1.90 compared to $1.45 in the same quarter last year, beating the Zacks Consensus Estimate of $1.71 [3]. - Revenues reached $1.018 billion, a nearly 6% increase year-over-year, but slightly missed the Zacks Consensus Estimate of $1.021 billion [4]. - The company announced 41 manufacturing program wins, expected to contribute $250 million in annualized revenues once fully ramped [5]. Market Sector Analysis - Industrial sector revenues increased 3% year-over-year to $415 million, contributing 41% to total revenues [6]. - Healthcare/Life Sciences revenues rose 10.5% to $420 million, also contributing 41% to total revenues [7]. - Aerospace/Defense revenues inched up 2.8% to $183 million, contributing 18% to total revenues [8]. Operating Metrics - Gross profit on a GAAP basis increased 9.4% year-over-year to $103.3 million, with a gross margin of 10.1% [10]. - Selling and administrative expenses rose 8.1% to $49.7 million, while adjusted operating margin expanded to 6% [10]. Cash Flow and Balance Sheet - As of June 28, 2025, cash and cash equivalents were $237.6 million, down from $310.5 million as of March 29 [12]. - Long-term debt increased to $92.2 million from $88.8 million [12]. - Cash flows from operations were $26.9 million, with free cash flow reported at $13.2 million [12]. Share Repurchase and Future Outlook - The company repurchased $18.4 million worth of shares and added $100 million to its buyback authorization [13]. - For Q4 fiscal 2025, revenues are anticipated to be between $1.025 billion and $1.065 billion, with non-GAAP EPS expected in the range of $1.82-$1.97 [14]. Market Sentiment - Estimates for Plexus have been trending upward since the earnings release, indicating positive investor sentiment [15][17]. - The stock has a VGM Score of A, reflecting strong growth potential, though it lags slightly in momentum [16].

PART I. FINANCIAL INFORMATION [ITEM 1. FINANCIAL STATEMENTS (Unaudited)](index=4&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS%20(Unaudited)) This section presents the unaudited condensed consolidated financial statements of Plexus Corp. and its subsidiaries, including statements of comprehensive income, balance sheets, shareholders' equity, and cash flows, along with detailed notes explaining the basis of presentation, accounting policies, and specific financial line items for the three and nine months ended June 28, 2025, and June 29, 2024 [Condensed Consolidated Statements of Comprehensive Income](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) This statement provides a summary of the company's revenues, expenses, and net income over specific interim periods Condensed Consolidated Statements of Comprehensive Income (in thousands) | Metric | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :--------------------------------- | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | Net sales | $1,018,308 | $960,751 | $2,974,600 | $2,910,258 | | Gross profit | $103,288 | $94,415 | $301,731 | $270,618 | | Operating income | $53,608 | $39,246 | $149,259 | $113,874 | | Net income | $45,116 | $25,140 | $121,456 | $70,594 | | Diluted Earnings per share | $1.64 | $0.91 | $4.39 | $2.53 | | Total comprehensive income | $78,729 | $18,106 | $130,701 | $79,192 | [Condensed Consolidated Balance Sheets](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) This statement presents the company's financial position, including assets, liabilities, and shareholders' equity, at specific interim dates Condensed Consolidated Balance Sheets (in thousands) | Metric | June 28, 2025 | September 28, 2024 | | :-------------------------- | :------------ | :----------------- | | Total assets | $3,105,633 | $3,153,821 | | Total liabilities | $1,686,548 | $1,828,996 | | Total shareholders' equity | $1,419,085 | $1,324,825 | | Cash and cash equivalents | $237,567 | $345,109 | | Inventories | $1,278,219 | $1,311,434 | [Condensed Consolidated Statements of Shareholders' Equity](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Shareholders'%20Equity) This statement details changes in the company's equity accounts, such as retained earnings and treasury stock, over interim periods Condensed Consolidated Statements of Shareholders' Equity (in thousands) | Metric | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Total stockholders' equity, end of period | $1,419,085 | $1,266,360 | | Retained earnings, end of period | $1,944,599 | $1,781,922 | | Common stock held in treasury, end of period | $(1,233,922) | $(1,170,574) | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) This statement summarizes the cash inflows and outflows from operating, investing, and financing activities for interim periods Condensed Consolidated Statements of Cash Flows (in thousands, Nine Months Ended) | Metric | June 28, 2025 | June 29, 2024 | | :-------------------------------------------------- | :------------ | :------------ | | Cash flows provided by operating activities | $117,213 | $216,371 | | Cash flows used in investing activities | $(60,853) | $(68,745) |\n| Cash flows used in financing activities | $(168,282) | $(134,305) | | Net (decrease) increase in cash and cash equivalents and restricted cash | $(109,845) | $13,236 | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) This section provides detailed explanations and disclosures for the condensed consolidated financial statements, covering accounting policies, significant estimates, and specific financial line items [1. Basis of Presentation](index=8&type=section&id=1.%20Basis%20of%20Presentation) This note outlines the accounting principles and methods used in preparing the interim financial statements - The financial statements are unaudited and prepared in accordance with SEC rules for interim financial statements, reflecting normal recurring adjustments[16](index=16&type=chunk) - In Q1 fiscal 2025, internal management reporting changed to focus on value-add sales and adjusted corporate cost allocation, but operating segments and reportable segments did not change, and there was no effect on consolidated net sales, operating income, or net income[20](index=20&type=chunk) - The Company is evaluating the impact of ASU 2024-03 Disaggregation of Income Statement Expense, effective Q4 fiscal 2028, and expects immaterial impacts from ASU 2023-07 Segment Reporting (adopting Q4 fiscal 2025) and ASU 2023-09 Income Taxes (adopting Q1 fiscal 2026)[21](index=21&type=chunk)[22](index=22&type=chunk)[24](index=24&type=chunk) [2. Inventories](index=9&type=section&id=2.%20Inventories) This note details the composition and valuation of the company's inventory balances Inventories (in thousands) | Category | June 28, 2025 | September 28, 2024 | | :--------------- | :------------ | :----------------- | | Raw materials | $1,117,282 | $1,184,222 | | Work-in-process | $56,529 | $49,513 | | Finished goods | $104,408 | $77,699 | | Total inventories| $1,278,219 | $1,311,434 | - Customer deposits related to inventory totaled **$420.6 million** as of June 28, 2025, down from **$536.2 million** as of September 28, 2024[26](index=26&type=chunk) [3. Debt, Finance Lease and Other Financing Obligations](index=9&type=section&id=3.%20Debt,%20Finance%20Lease%20and%20Other%20Financing%20Obligations) This note provides information on the company's various debt instruments, finance leases, and other financing commitments Debt and Finance Lease Obligations (in thousands) | Obligation | June 28, 2025 | September 28, 2024 | | :------------------------------------------------ | :------------ | :----------------- | | 4.05% Senior Notes, due June 15, 2025 | $— | $100,000 | | 4.22% Senior Notes, due June 15, 2028 | $50,000 | $50,000 | | Borrowings under the Credit Facility | $45,000 | $50,000 | | Finance lease and other financing obligations | $48,458 | $48,142 | | Total obligations | $142,893 | $247,318 | - The Company repaid **$100.0 million** of its 4.05% Senior Notes on maturity on June 15, 2025[28](index=28&type=chunk) - Average daily borrowings under the Credit Facility decreased significantly to **$33.3 million** for the nine months ended June 28, 2025, from **$292.1 million** in the prior year period[28](index=28&type=chunk) [4. Derivatives and Fair Value Measurements](index=10&type=section&id=4.%20Derivatives%20and%20Fair%20Value%20Measurements) This note describes the company's use of derivative instruments and fair value measurement methodologies - The Company uses derivatives to manage foreign currency obligations and does not enter into them for speculative purposes[30](index=30&type=chunk) Derivative Instruments Notional Value (in millions) | Type | June 28, 2025 | September 28, 2024 | | :-------------------------------- | :------------ | :----------------- | | Cash flow hedges outstanding | $243.0 | $186.5 | | Non-designated forward contracts | $103.6 | $144.0 | - An estimated **$10.4 million** of unrealized gains (net of tax) related to cash flow hedges are expected to be reclassified into earnings within the next twelve months[31](index=31&type=chunk) [5. Income Taxes](index=12&type=section&id=5.%20Income%20Taxes) This note explains the components of income tax expense and the effective tax rates for the reporting periods Income Tax Expense (in thousands) | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Three Months Ended | $4,720 | $5,164 | | Nine Months Ended | $16,897 | $13,524 | Effective Tax Rates | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Three Months Ended | 9.5% | 17.0% | | Nine Months Ended | 12.2% | 16.1% | - The lower effective tax rates for the three and nine months ended June 28, 2025, were primarily due to increases in discrete tax benefits of **$2.9 million** and **$4.4 million**, respectively, including a **$3.3 million** state valuation allowance release[44](index=44&type=chunk) [6. Earnings Per Share](index=13&type=section&id=6.%20Earnings%20Per%20Share) This note presents the basic and diluted earnings per share calculations for the company's common stock Earnings Per Share | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Basic EPS (3 months) | $1.67 | $0.92 | | Diluted EPS (3 months) | $1.64 | $0.91 | | Basic EPS (9 months) | $4.48 | $2.57 | | Diluted EPS (9 months) | $4.39 | $2.53 | [7. Leases](index=13&type=section&id=7.%20Leases) This note provides details on the company's lease arrangements, including lease assets, liabilities, and related expenses Total Lease Expense (in thousands) | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Three Months Ended | $6,892 | $7,317 | | Nine Months Ended | $19,946 | $21,535 | Lease Assets and Liabilities (in thousands) | Metric | June 28, 2025 | September 28, 2024 | | :-------------------- | :------------ | :----------------- | | Total lease assets | $111,552 | $110,213 | | Total lease liabilities | $84,827 | $90,445 | [8. Share-Based Compensation](index=15&type=section&id=8.%20Share-Based%20Compensation) This note describes the company's share-based compensation plans and the associated expense recognized Share-Based Compensation Expense (in millions) | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Three Months Ended | $7.7 | $7.2 | | Nine Months Ended | $21.8 | $19.6 | [9. Litigation](index=15&type=section&id=9.%20Litigation) This note discloses information regarding any legal proceedings or claims involving the company - The Company is involved in lawsuits in the ordinary course of business but management does not believe they will have a material positive or adverse effect on its financial position, results of operations, or cash flows[54](index=54&type=chunk)[55](index=55&type=chunk) [10. Reportable Segments](index=15&type=section&id=10.%20Reportable%20Segments) This note provides financial information disaggregated by the company's operating segments Net Sales by Reportable Segment (in thousands) | Segment | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :------ | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | AMER | $311,770 | $306,522 | $880,836 | $912,452 | | APAC | $593,509 | $520,928 | $1,787,666 | $1,595,427 | | EMEA | $117,125 | $136,670 | $320,975 | $410,239 | Operating Income by Reportable Segment (in thousands) | Segment | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :------ | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | AMER | $28,671 | $23,964 | $70,955 | $58,394 | | APAC | $83,820 | $75,285 | $253,807 | $225,295 | | EMEA | $5,887 | $9,287 | $14,183 | $22,213 | [11. Guarantees](index=16&type=section&id=11.%20Guarantees) This note details the company's various guarantee obligations, including product warranties and indemnifications - The Company provides indemnifications under customer manufacturing agreements and offers a limited warranty (12-24 months) covering workmanship and materials, generally limited to repair or replacement[60](index=60&type=chunk)[61](index=61&type=chunk) Limited Warranty Liability (in thousands, Nine Months Ended) | Metric | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Reserve balance, beginning of period | $6,752 | $5,821 | | Accruals for warranties issued | $2,169 | $1,885 | | Settlements | $(1,078) | $(1,186) | | Reserve balance, end of period | $7,843 | $6,520 | [12. Shareholders' Equity](index=17&type=section&id=12.%20Shareholders'%20Equity) This note provides information on changes in the company's shareholders' equity, including share repurchase programs - The 2025 Share Repurchase Program, authorized for **$50.0 million**, saw **314,344 shares** repurchased for **$43.4 million** (average price **$138.19/share**) during the nine months ended June 28, 2025. The remaining **$6.6 million** authority has since been fully expended[66](index=66&type=chunk) - A new 2026 Share Repurchase Program was approved on May 14, 2025, authorizing up to **$100.0 million** of common stock repurchases, effective upon completion of the 2025 Program with no expiration[67](index=67&type=chunk) [13. Trade Accounts Receivable Sale Programs](index=17&type=section&id=13.%20Trade%20Accounts%20Receivable%20Sale%20Programs) This note describes the company's programs for selling trade accounts receivable to third parties - The Company utilizes uncommitted Master Accounts Receivable Purchase Agreements (e.g., MUFG RPA, HSBC RPA) to sell receivables at a discount, with maximum facility amounts of **$340.0 million** and **$70.0 million**, respectively[69](index=69&type=chunk) Trade Accounts Receivable Sold (in millions) | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Three Months Ended | $179.6 | $201.4 | | Nine Months Ended | $502.6 | $638.8 | - As of June 28, 2025, **$191.8 million** of accounts receivables sold remained outstanding and subject to servicing by the Company, down from **$220.2 million** on September 28, 2024[73](index=73&type=chunk) [14. Revenue from Contracts with Customers](index=18&type=section&id=14.%20Revenue%20from%20Contracts%20with%20Customers) This note provides disaggregated revenue information and details on contract assets and deferred revenue - Approximately **85%** of the Company's revenue for both the three and nine months ended June 28, 2025, was recognized over time, compared to **83%** in the prior year periods[83](index=83&type=chunk) Net Sales by Market Sector (in thousands) | Market Sector | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :---------------------- | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | Aerospace/Defense | $183,217 | $177,629 | $515,463 | $514,949 | | Healthcare/Life Sciences| $420,422 | $380,009 | $1,205,153 | $1,139,353 | | Industrial | $414,669 | $403,113 | $1,253,984 | $1,255,956 | - Contract assets increased to **$145.1 million** as of June 28, 2025, from **$120.6 million** at the beginning of the nine-month period, while deferred revenue from advanced payments was **$159.5 million**[85](index=85&type=chunk) [15. Restructuring and Non-recurring Charges](index=20&type=section&id=15.%20Restructuring%20and%20Non-recurring%20Charges) This note details costs associated with restructuring activities and other non-recurring items - No restructuring and other charges were incurred for the three months ended June 28, 2025. For the nine months ended June 28, 2025, restructuring costs were **$4.7 million**, primarily severance in EMEA and AMER regions[87](index=87&type=chunk) - For the nine months ended June 29, 2024, restructuring and other charges totaled **$20.3 million**, including severance and site closure costs in AMER and EMEA, partially offset by insurance proceeds[88](index=88&type=chunk) Restructuring Accrual Balance (in thousands) | Period | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Accrual balance, end of period | $311 | $6,200 | [ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](index=21&type=section&id=ITEM%202.%20MANAGEMENT'S%20DISCUSSION%20AND%20ANALYSIS%20OF%20FINANCIAL%20CONDITION%20AND%20RESULTS%20OF%20OPERATIONS) This section provides management's perspective on the company's financial performance, condition, and future outlook, analyzing short-term results and prospects ["Safe Harbor" Cautionary Statement Under the Private Securities Litigation Reform Act of 1995](index=21&type=section&id=Safe%20Harbor%20Cautionary%20Statement%20Under%20the%20Private%20Securities%20Litigation%20Reform%20Act%20of%201995) This statement warns readers about forward-looking statements and the inherent risks and uncertainties that could cause actual results to differ materially - The report contains forward-looking statements that involve risks and uncertainties, including those related to tariffs, inflation, component shortages, customer delays, and global economic conditions, which could cause actual results to differ materially[90](index=90&type=chunk) [Overview](index=21&type=section&id=Overview) This section provides a high-level summary of the company's business, operations, and strategic focus - Plexus designs, manufactures, and services highly complex products for the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by over **20,000 team members** across **26 facilities** globally[91](index=91&type=chunk) [Results of Operations](index=22&type=section&id=Results%20of%20Operations) This section details the consolidated financial performance, including net sales, cost of sales, gross profit, operating income, other expenses, income taxes, net income, and diluted earnings per share [Consolidated Performance Summary](index=22&type=section&id=Consolidated%20Performance%20Summary) This summary provides key financial metrics and ratios reflecting the company's overall performance Consolidated Performance Summary (dollars in millions, except per share data) | Metric | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :----------------------- | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | Net sales | $1,018.3 | $960.8 | $2,974.6 | $2,910.3 | | Gross margin | 10.1% | 9.8% | 10.1% | 9.3% | | Operating margin | 5.3% | 4.1% | 5.0% | 3.9% | | Net income | $45.1 | $25.1 | $121.5 | $70.6 | | Diluted earnings per share | $1.64 | $0.91 | $4.39 | $2.53 | [Net sales](index=22&type=section&id=Net%20sales) This section analyzes the company's revenue performance, including changes by segment and market sector - Net sales increased by **$57.5 million (6.0%)** for the three months ended June 28, 2025, and by **$64.3 million (2.2%)** for the nine months ended June 28, 2025, compared to the prior year periods[95](index=95&type=chunk) Net Sales by Reportable Segment (in millions) | Segment | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :------ | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | AMER | $311.7 (↑ 1.7%) | $306.5 | $880.8 (↓ 3.5%) | $912.5 | | APAC | $593.5 (↑ 13.9%) | $521.0 | $1,787.7 (↑ 12.0%) | $1,595.5 | | EMEA | $117.1 (↓ 14.3%) | $136.7 | $321.0 (↓ 21.7%) | $410.2 | Net Sales by Market Sector (in millions) | Market Sector | Three Months Ended June 28, 2025 | Three Months Ended June 29, 2024 | Nine Months Ended June 28, 2025 | Nine Months Ended June 29, 2024 | | :----------------------- | :------------------------------- | :------------------------------- | :------------------------------ | :------------------------------ | | Aerospace/Defense | $183.2 (↑ 3.2%) | $177.6 | $515.4 (↑ 0.1%) | $515.0 | | Healthcare/Life Sciences | $420.4 (↑ 10.6%) | $380.1 | $1,205.2 (↑ 5.8%) | $1,139.4 | | Industrial | $414.7 (↑ 2.9%) | $403.1 | $1,254.0 (↓ 0.2%) | $1,255.9 | [Cost of sales](index=24&type=section&id=Cost%20of%20sales) This section discusses the factors influencing the cost of goods sold and its impact on profitability - Cost of sales increased by **$48.7 million (5.6%)** for the three months and **$33.3 million (1.3%)** for the nine months ended June 28, 2025, primarily driven by increased net sales[110](index=110&type=chunk) - For the nine months, the increase was partially offset by a positive shift in customer mix and a decrease in fixed costs due to operational efficiency initiatives[111](index=111&type=chunk) - Approximately **88%** of total cost of sales was variable, with **87%** related to material and component costs[110](index=110&type=chunk) [Gross profit](index=24&type=section&id=Gross%20profit) This section examines the company's gross profit and gross margin trends, highlighting drivers of change - Gross profit increased by **$8.9 million (9.4%)** for the three months and **$31.1 million (11.5%)** for the nine months ended June 28, 2025[112](index=112&type=chunk)[113](index=113&type=chunk) - Gross margin improved by **30 basis points** to **10.1%** for the three months and by **80 basis points** to **10.1%** for the nine months, primarily due to lower costs from operational efficiencies and prior restructuring activities[112](index=112&type=chunk)[113](index=113&type=chunk) [Operating income](index=24&type=section&id=Operating%20income) This section analyzes the company's operating income and margin, including segment-specific performance - Operating income increased by **$14.4 million (36.7%)** for the three months and **$35.4 million (31.1%)** for the nine months ended June 28, 2025[114](index=114&type=chunk)[115](index=115&type=chunk) - Operating margin improved by **120 basis points** to **5.3%** for the three months and by **110 basis points** to **5.0%** for the nine months, driven by decreased restructuring charges and increased gross profit, partially offset by higher selling and administrative expenses[114](index=114&type=chunk)[115](index=115&type=chunk) - AMER segment operating income increased by **$4.8 million** (3 months) and **$12.6 million** (9 months) due to increased sales, decreased fixed costs, and positive customer mix[116](index=116&type=chunk)[117](index=117&type=chunk) - APAC segment operating income increased by **$8.5 million** (3 months) and **$28.5 million** (9 months) due to increased sales, partially offset by negative customer mix and increased fixed costs/S&A[118](index=118&type=chunk)[119](index=119&type=chunk) - EMEA segment operating income decreased by **$3.4 million** (3 months) and **$8.0 million** (9 months) due to decreased sales, partially offset by decreased fixed costs and positive customer mix (9 months)[120](index=120&type=chunk)[121](index=121&type=chunk) [Other expense](index=25&type=section&id=Other%20expense) This section details non-operating expenses, such as interest expense and factoring fees - Other expense decreased by **$5.1 million** for the three months and **$18.9 million** for the nine months ended June 28, 2025[122](index=122&type=chunk)[123](index=123&type=chunk) - This decrease was primarily driven by lower interest expense (**$4.9 million** for 3 months, **$14.1 million** for 9 months) due to reduced credit facility borrowings, and decreased factoring fees[122](index=122&type=chunk)[123](index=123&type=chunk) [Income taxes](index=25&type=section&id=Income%20taxes) This section discusses income tax expense, effective tax rates, and significant tax-related items - Income tax expense decreased for the three months ended June 28, 2025, to **$4.7 million** (from **$5.2 million**), but increased for the nine months to **$16.9 million** (from **$13.5 million**)[124](index=124&type=chunk) - The decrease for three months was due to a **$2.9 million** increase in discrete tax benefits; the increase for nine months was due to higher pre-tax income, partially offset by a **$4.4 million** increase in discrete tax benefits[124](index=124&type=chunk) - The expected annual effective tax rate for fiscal 2025 is **10.0% to 12.0%**. The Company is evaluating the impact of the recently enacted "One Big Beautiful Bill Act" on its financial statements[126](index=126&type=chunk)[127](index=127&type=chunk) [Net income](index=26&type=section&id=Net%20income) This section analyzes the company's net income and the factors contributing to its changes - Net income increased by **$20.0 million (79.7%)** to **$45.1 million** for the three months and by **$50.9 million (72.1%)** to **$121.5 million** for the nine months ended June 28, 2025[128](index=128&type=chunk)[129](index=129&type=chunk) - This growth was primarily driven by increased operating income and decreased other expenses, with tax expense also decreasing for the three-month period[128](index=128&type=chunk)[129](index=129&type=chunk) [Diluted earnings per share](index=26&type=section&id=Diluted%20earnings%20per%20share) This section discusses the diluted earnings per share and its drivers, reflecting profitability per share - Diluted EPS increased to **$1.64** for the three months and **$4.39** for the nine months ended June 28, 2025, up from **$0.91** and **$2.53**, respectively, in the prior year periods, primarily due to increased net income[130](index=130&type=chunk) [Return on Invested Capital ("ROIC") and economic return](index=26&type=section&id=Return%20on%20Invested%20Capital%20(%22ROIC%22)%20and%20economic%20return) This section evaluates the company's efficiency in generating returns from its capital investments ROIC and Economic Return (Nine Months Ended) | Metric | June 28, 2025 | June 29, 2024 | | :-------------------- | :------------ | :------------ | | After-tax ROIC | 14.1% | 10.4% | | WACC | 8.9% | 8.2% | | Economic return | 5.2% | 2.2% | - The Company aims for an ROIC goal of **15%**, exceeding its Weighted Average Cost of Capital (WACC) by over **500 basis points** to create shareholder value[131](index=131&type=chunk) [Liquidity and Capital Resources](index=27&type=section&id=Liquidity%20and%20Capital%20Resources) This section discusses the company's cash position, sources of liquidity, and capital allocation strategies, including cash flow analysis from operating, investing, and financing activities, cash cycle days, and free cash flow [Cash Flows](index=27&type=section&id=Cash%20Flows) This section provides an overview of the company's cash and cash equivalents and their changes - Cash and cash equivalents and restricted cash decreased to **$237.6 million** as of June 28, 2025, from **$347.5 million** as of September 28, 2024[136](index=136&type=chunk) - **92%** of the Company's cash and cash equivalents balance was held outside of the U.S. by foreign subsidiaries as of June 28, 2025[137](index=137&type=chunk) - Projected cash flows from operations, available cash, potential borrowings under the Credit Facility, and leasing capabilities are expected to be sufficient to meet working capital and fixed capital requirements for the next twelve months[137](index=137&type=chunk)[157](index=157&type=chunk) [Operating Activities](index=27&type=section&id=Operating%20Activities) This section details the cash generated or used by the company's primary business operations - Cash flows provided by operating activities decreased to **$117.2 million** for the nine months ended June 28, 2025, from **$216.4 million** in the prior year[139](index=139&type=chunk) - The decrease was primarily due to lower cash flows from inventory (down **$94.0 million**), advanced payments from customers (down **$93.0 million**), accounts receivable (down **$56.3 million**), and contract assets (down **$50.1 million**)[139](index=139&type=chunk) - This was partially offset by a **$50.9 million** increase in net income and a **$128.1 million** improvement in accounts payables cash flows[139](index=139&type=chunk) [Cash Cycle Days](index=28&type=section&id=Cash%20Cycle%20Days) This section analyzes the efficiency of the company's working capital management over time Cash Cycle Days (Three Months Ended) | Metric | June 28, 2025 | June 29, 2024 | | :---------------------- | :------------ | :------------ | | Days in accounts receivable | 59 | 61 | | Days in contract assets | 13 | 11 | | Days in inventory | 128 | 151 | | Days in accounts payable | (72) | (62) | | Days in advanced payments | (59) | (78) | | Annualized cash cycle | 69 | 83 | - Annualized cash cycle days decreased by **14 days** to **69 days** as of June 28, 2025, compared to June 29, 2024[141](index=141&type=chunk) - This improvement was primarily driven by a **23-day** decrease in days in inventory due to reduction efforts and lower working capital investments, and a **19-day** decrease in days in advanced payments[143](index=143&type=chunk)[144](index=144&type=chunk) [Free Cash Flow](index=28&type=section&id=Free%20Cash%20Flow) This section presents the cash available to the company after accounting for capital expenditures Free Cash Flow (in millions, Nine Months Ended) | Metric | June 28, 2025 | June 29, 2024 | | :-------------------------------- | :------------ | :------------ | | Cash flows provided by operating activities | $117.2 | $216.4 | | Payments for property, plant and equipment | $(60.4) | $(68.9) | | Free cash flow | $56.8 | $147.5 | - Free Cash Flow (FCF) decreased by **$90.7 million** to **$56.8 million** for the nine months ended June 28, 2025, compared to **$147.5 million** in the prior year[145](index=145&type=chunk) [Investing Activities](index=29&type=section&id=Investing%20Activities) This section details the cash flows related to the acquisition and disposal of long-term assets - Cash flows used in investing activities decreased to **$60.8 million** for the nine months ended June 28, 2025, from **$68.8 million** in the prior year, primarily due to an **$8.4 million** decrease in capital expenditures[148](index=148&type=chunk) - Estimated capital expenditures for fiscal 2025 are projected to be between **$80.0 million** and **$100.0 million**[148](index=148&type=chunk) [Financing Activities](index=29&type=section&id=Financing%20Activities) This section describes the cash flows associated with debt, equity, and dividend transactions - Cash flows used in financing activities increased to **$168.3 million** for the nine months ended June 28, 2025, from **$134.3 million** in the prior year[149](index=149&type=chunk) - This increase was primarily due to higher net debt repayments, including the **$100.0 million** repayment of 4.05% Senior Notes and **$5.0 million** net repayments on the credit facility (compared to **$83.0 million** in 2024), along with a **$7.7 million** increase in common stock repurchases[149](index=149&type=chunk)[153](index=153&type=chunk) - The Company repurchased **314,344 shares** for **$43.4 million** under the 2025 Program during the nine months ended June 28, 2025, and approved a new **$100.0 million** 2026 Program[152](index=152&type=chunk)[153](index=153&type=chunk) [Disclosure About Critical Accounting Estimates](index=31&type=section&id=Disclosure%20About%20Critical%20Accounting%20Estimates) This section highlights the accounting estimates that require significant judgment and could materially impact financial results - There were no material changes to the Company's critical accounting policies during the third quarter of fiscal 2025[158](index=158&type=chunk) [New Accounting Pronouncements](index=31&type=section&id=New%20Accounting%20Pronouncements) This section discusses recently issued accounting standards and their potential impact on the company's financial statements - Refer to Note 1, "Recently Issued Accounting Pronouncements Not Yet Adopted," for details on new accounting pronouncements[159](index=159&type=chunk) [ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](index=31&type=section&id=ITEM%203.%20QUANTITATIVE%20AND%20QUALITATIVE%20DISCLOSURES%20ABOUT%20MARKET%20RISK) This section discusses the company's exposure to market risks, specifically foreign currency risk and interest rate risk, and how these risks are managed [Foreign Currency Risk](index=31&type=section&id=Foreign%20Currency%20Risk) This section assesses the company's exposure to fluctuations in foreign exchange rates and its hedging strategies - The Company selectively hedges foreign currency denominated transactions to offset exchange rate changes, primarily using foreign currency contracts for non-functional currency assets and liabilities[161](index=161&type=chunk) Percentages of Transactions Denominated in Non-U.S. Dollar Currencies (Three Months Ended) | Metric | June 28, 2025 | June 29, 2024 | | :---------- | :------------ | :------------ | | Net Sales | 9% | 12% | | Total Costs | 18% | 18% | - A **10.0%** change in the U.S. dollar's value relative to other transactional currencies would not have a material effect on the Company's financial position, results of operations, or cash flows as of June 28, 2025[162](index=162&type=chunk) [Interest Rate Risk](index=32&type=section&id=Interest%20Rate%20Risk) This section evaluates the company's exposure to changes in interest rates, particularly on its variable-rate debt - The Company's primary objective for investment activities is to preserve principal while maximizing yields without significantly increasing market risk[163](index=163&type=chunk) - The material interest rate risk is associated with the Credit Facility, which bears variable interest rates (e.g., SOFR plus **1.00%** as of June 28, 2025)[164](index=164&type=chunk) - A **10.0%** change in interest rates would not have a material effect on the Company's financial position, results of operations, or cash flows as of June 28, 2025[164](index=164&type=chunk) [ITEM 4. CONTROLS AND PROCEDURES](index=32&type=section&id=ITEM%204.%20CONTROLS%20AND%20PROCEDURES) This section details the company's disclosure controls and procedures and reports on any changes in internal control over financial reporting [Disclosure Controls and Procedures](index=32&type=section&id=Disclosure%20Controls%20and%20Procedures) This section describes the effectiveness of the company's controls designed to ensure timely and accurate financial disclosures - The CEO and CFO concluded that the Company's disclosure controls and procedures were effective at a reasonable assurance level as of June 28, 2025[165](index=165&type=chunk) [Changes in Internal Control Over Financial Reporting](index=32&type=section&id=Changes%20in%20Internal%20Control%20Over%20Financial%20Reporting) This section reports on any material changes to the company's internal control over financial reporting during the period - There were no changes in the Company's internal control over financial reporting during the third quarter of fiscal 2025 that materially affected, or are reasonably likely to materially affect, internal control over financial reporting[166](index=166&type=chunk) PART II. OTHER INFORMATION [ITEM 1A. Risk Factors](index=33&type=section&id=ITEM%201A.%20Risk%20Factors) This section refers to the risk factors previously disclosed in the company's Annual Report on Form 10-K for fiscal year ended September 28, 2024, noting no material changes during the current period - No material changes to the risk factors set forth in Part I, Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended September 28, 2024[167](index=167&type=chunk) [ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=33&type=section&id=ITEM%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details the company's share repurchase activities during the three months ended June 28, 2025, under its publicly announced programs Share Repurchases (Three Months Ended June 28, 2025) | Period | Total shares purchased | Average price paid per share | | :------------------------ | :--------------------- | :--------------------------- | | March 30, 2025-April 26, 2025 | 32,397 | $120.59 | | April 27, 2025 - May 24, 2025 | 48,345 | $129.71 | | May 25, 2025-June 28, 2025 | 62,540 | $132.13 | | Total | 143,282 | $128.70 | - As of June 28, 2025, **$6.6 million** of authority remained under the 2025 Program, which has since been fully expended[168](index=168&type=chunk) - The Board of Directors approved a new **$100.0 million** 2026 Share Repurchase Program on May 14, 2025, effective upon completion of the 2025 Program with no expiration[169](index=169&type=chunk) [ITEM 5. Other Information](index=33&type=section&id=ITEM%205.%20Other%20Information) This section states that there were no directors or Section 16 officers who adopted or terminated Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the three months ended June 28, 2025 - No directors or Section 16 officers adopted or terminated Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the three months ended June 28, 2025[170](index=170&type=chunk) [ITEM 6. Exhibits](index=35&type=section&id=ITEM%206.%20Exhibits) This section lists all exhibits filed with the Form 10-Q, including certifications, reconciliation of non-GAAP financial measures, and XBRL-formatted financial statements - Exhibits include certifications from the President and CEO (31.1, 32.1) and Chief Financial Officer (31.2, 32.2) pursuant to the Sarbanes-Oxley Act of 2002[172](index=172&type=chunk) - Exhibit 99.1 provides a reconciliation of ROIC to GAAP and Economic Return Financial Statements[172](index=172&type=chunk) - Exhibit 101 contains the Condensed Consolidated Financial Statements and Notes formatted in Inline Extensible Business Reporting Language (XBRL)[172](index=172&type=chunk) [SIGNATURES](index=36&type=section&id=SIGNATURES) This section contains the official signatures of the registrant's authorized officers, including the President and Chief Executive Officer, and the Executive Vice President and Chief Financial Officer, certifying the report - The report was signed by Todd P. Kelsey, President and Chief Executive Officer, and Patrick J. Jermain, Executive Vice President and Chief Financial Officer, on August 1, 2025[175](index=175&type=chunk)

Core Insights - Plexus Corp. reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.90, an increase from $1.45 in the same quarter last year, surpassing the Zacks Consensus Estimate of $1.71 per share [1][7] - Revenues reached $1.018 billion, a nearly 6% year-over-year increase, but slightly missed the Zacks Consensus Estimate of $1.021 billion [2][7] Revenue Breakdown - Revenues from the Americas increased by 2%, while EMEA sales declined by 14.6%. Asia-Pacific revenues surged by 14% to $594 million [2] - The Industrial sector's revenues rose by 3% year over year to $415 million, contributing 41% to total revenues. The Healthcare/Life Sciences sector saw a 10.5% increase to $420 million, also contributing 41% [4][5] - Aerospace/Defense revenues inched up by 2.8% year over year to $183 million, contributing 18% to total revenues [8] Operational Highlights - Plexus secured 41 new manufacturing program wins, expected to generate $250 million in annualized revenues once fully ramped into production [3][7] - Gross profit on a GAAP basis increased by 9.4% year over year to $103.3 million, with a gross margin of 10.1% [10] Cash Flow and Balance Sheet - As of June 28, 2025, Plexus had cash and cash equivalents of $237.6 million, down from $310.5 million as of March 29 [11] - The company reported cash flows from operations of $26.9 million and free cash flow of $13.2 million for the quarter [11] Share Repurchase Program - Plexus repurchased $18.4 million worth of shares at an average price of $128.70 per share and added another $100 million to its existing buyback authorization [12] Q4 Outlook - For the fourth quarter of fiscal 2025, Plexus anticipates revenues between $1.025 billion and $1.065 billion, with non-GAAP EPS expected in the range of $1.82 to $1.97 [13]

Financial Data and Key Metrics Changes - Revenue for the fiscal third quarter was $1,018,000,000, meeting guidance and showing sequential growth [6][5] - Non-GAAP operating margin was 6%, increasing 30 basis points sequentially and meeting the stated goal [7][5] - Non-GAAP EPS of $1.9 exceeded guidance, benefiting from strong operating performance and lower interest expense [8][24] - Free cash flow for the quarter was $13,200,000, significantly better than expectations [8][25] - The company is forecasting fiscal fourth quarter revenue between $1,025,000,000 and $1,065,000, with a non-GAAP operating margin of 5.7% to 6.1% [13][28] Business Line Data and Key Metrics Changes - Aerospace and Defense sector revenue increased 6% sequentially, with new program ramps contributing to performance [15] - Healthcare Life Sciences sector revenue was up 2% sequentially, below expectations due to a customer design update [17] - Industrial sector revenue increased 4% sequentially, with strong demand in broadband communications and energy markets [19] Market Data and Key Metrics Changes - The funnel of qualified manufacturing opportunities increased 4% sequentially to $3,600,000,000, indicating robust growth prospects [22] - The company observed early signs of increasing activity in the European defense sector, which is expected to contribute positively moving forward [6][15] Company Strategy and Development Direction - The company is focused on enabling customer success and driving operational efficiency to sustain strong financial performance [14] - Strategic investments are aimed at creating long-term shareholder value and expanding market share [6][14] - The company anticipates healthy year-over-year revenue growth across all market sectors for fiscal 2026, without assuming end market demand improvement [13][14] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing strength in new program wins and opportunities to gain market share, despite evolving program ramp timelines and tariff-related uncertainties [6][7] - The company is optimistic about growth opportunities in the aerospace and defense sectors, particularly in Europe [15][80] - Management expects to maintain strong operating margins and free cash flow performance in the upcoming fiscal year [13][14] Other Important Information - The company has reduced its debt while accelerating share repurchase activity, with a new authorization of $100,000,000 [5][13] - The cash cycle at the end of the fiscal third quarter was 69 days, consistent with expectations [26] Q&A Session Summary Question: Can you provide more color on the semi cap pushouts? - Management indicated that the pushouts are specific to certain programs and are not indicative of perishable demand, with Q4 buoyed by new program ramps [34][35] Question: What is the outlook for the aerospace sector? - Management noted that there is still no pull from Boeing or Airbus for increased production, but strong demand is seen in defense and space subsectors [36][37] Question: What is the expected impact of the new facility in Malaysia? - The startup expenses are expected to be minimal, with a quick ramp to profitability anticipated due to existing new business [44][46] Question: How is the healthcare life sciences sector expected to perform? - Management expressed optimism for fiscal 2026 based on ongoing and new program ramps, as well as increased activity in engineering design services [76][78] Question: What are the expectations regarding tariffs? - Management reported limited impact from tariffs, with customers in a wait-and-see mode, and noted strong compliance efforts in their Mexico operations [66][67]

Financial Data and Key Metrics Changes - Revenue for the fiscal third quarter was $1,018 million, meeting guidance, with a sequential increase observed [5][6] - Non-GAAP operating margin was 6%, increasing by 30 basis points sequentially, achieving the goal of 6% or greater for three of the last four quarters [6][25] - Non-GAAP EPS was $1.9, exceeding guidance due to strong operating performance and lower interest expense [7][25] - Free cash flow for the quarter was $13.2 million, significantly better than expectations, contributing to a projected $100 million for fiscal 2025 [7][27] Business Line Data and Key Metrics Changes - Aerospace and Defense sector revenue increased by 6% sequentially, with new program ramps contributing to performance [16] - Healthcare Life Sciences sector revenue was up 2% sequentially, below expectations due to a customer design update causing temporary delays [18] - Industrial sector revenue increased by 4% sequentially, with strong demand in broadband communications and energy markets [20] Market Data and Key Metrics Changes - The funnel of qualified manufacturing opportunities increased by 4% sequentially to $3.6 billion, indicating robust growth prospects [22] - The company observed early signs of increasing activity in the European defense sector, which is expected to contribute positively moving forward [6][18] Company Strategy and Development Direction - The company is focused on enabling customer success and driving operational efficiency, which is expected to sustain strong financial performance [14] - Strategic investments are aimed at creating long-term shareholder value through improved profitability and free cash flow [5][14] - The company anticipates healthy year-over-year revenue growth across all market sectors for fiscal 2026, without assuming improvements in end market demand [13][14] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing strength in new program wins and opportunities to gain market share, despite uncertainties from tariffs and evolving program ramp timelines [6][12] - The outlook for fiscal fourth quarter includes expected revenue growth and strong financial performance, with guidance for revenue between $1,025 million and $1,065 million [13][30] - Management expressed optimism about the defense sector, particularly in Europe, and the potential for increased demand in fiscal 2026 [18][84] Other Important Information - The company has been recognized as a top workplace and has received accolades for its commitment to sustainability and community engagement [10][11] - The company has reduced total debt by over $200 million since last year's fiscal third quarter, maintaining a strong balance sheet [31] Q&A Session Summary Question: Can you provide more color on the semi cap pushouts? - Management clarified that the pushouts are specific to certain programs and do not indicate perishable demand, with Q4 buoyed by new program ramps in the semi cap subsector [36][37] Question: What is the outlook for the aerospace and defense side? - Management noted that while there is still no pull from Boeing or Airbus, strong demand is observed in defense and space subsectors, with expectations for future increases [38][39] Question: What is the guidance for the industrial business? - Management indicated that semi cap is a significant part of the industrial business, with a forecast of low double-digit growth for fiscal 2025, down from mid-teens previously [45] Question: What are the expectations for the new facility in Malaysia? - Management expects minimal drag from startup expenses and anticipates a quick ramp to profitability, focusing initially on semi cap and healthcare sectors [47][51] Question: How is the engineering solutions segment performing? - Management highlighted that engineering solutions are a significant differentiator, contributing over $100 million in revenue, with strong growth and profitability expected [58][60] Question: What is the impact of tariffs on demand? - Management reported limited changes due to tariffs, with most customers in a wait-and-see mode, and noted strong compliance efforts in their Mexico operations [68] Question: What are the expectations for cash cycle days? - Management guided for cash cycle days to improve to the mid-60s, with ongoing efforts to reduce inventory days [70]

FISCAL THIRD QUARTER 2025 HIGHLIGHTS July 23, 2025 PLEXUS CONFIDENTIAL SAFE HARBOR AND FAIR DISCLOSURE STATEMENT Some of the statements made and information provided during our call as well as information included in the supporting materials will be forward looking statements, including, without limitation, those regarding revenue, gross margin, selling and administrative expense, operating margin, other income and expense, taxes, cash cycle, capital allocation and future business outlook. Forward-looking s ...

Earnings Performance - Plexus reported quarterly earnings of $1.9 per share, exceeding the Zacks Consensus Estimate of $1.71 per share, and up from $1.45 per share a year ago, representing an earnings surprise of +11.11% [1] - The company has surpassed consensus EPS estimates in all four of the last quarters [2] Revenue Analysis - Plexus posted revenues of $1.02 billion for the quarter ended June 2025, which missed the Zacks Consensus Estimate by 0.27%, compared to year-ago revenues of $960.75 million [2] - The company has only topped consensus revenue estimates once in the last four quarters [2] Stock Performance and Outlook - Plexus shares have declined approximately 14.6% since the beginning of the year, while the S&P 500 has gained 7.3% [3] - The current consensus EPS estimate for the upcoming quarter is $1.84 on revenues of $1.09 billion, and for the current fiscal year, it is $6.95 on revenues of $4.07 billion [7] Industry Context - The Electronics - Manufacturing Services industry, to which Plexus belongs, is currently ranked in the top 6% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Financial Performance - Plexus reported fiscal third quarter 2025 revenue of $1.018 billion, with a GAAP operating margin of 5.3% and diluted EPS of $1.64[5] - Non-GAAP operating margin for the third quarter was 6.0%, and non-GAAP diluted EPS was $1.90, excluding $0.26 of stock-based compensation expense[5] - Net sales for Q3 2025 reached $1,018,308, an increase of 6.0% compared to $960,751 in Q3 2024[20] - Gross profit for Q3 2025 was $103,288, representing a gross margin of 10.1%, up from $94,415 and a margin of 9.8% in Q3 2024[20] - Operating income for Q3 2025 increased to $53,608, a 36.6% rise from $39,246 in Q3 2024[20] - Net income for Q3 2025 was $45,116, compared to $25,140 in Q3 2024, marking an increase of 79.5%[20] - Diluted earnings per share for Q3 2025 were $1.64, up from $0.91 in Q3 2024, reflecting an increase of 80.2%[20] - Non-GAAP operating income for Q3 2025 was $61,299, compared to $55,670 in Q3 2024, an increase of 10.3%[24] - Adjusted diluted earnings per share for Q3 2025 were $1.90, up from $1.45 in Q3 2024, reflecting an increase of 31.0%[24] - Adjusted operating income for the nine months ended June 28, 2025, was $153,942 million, compared to $135,023 million for the same period in 2024, reflecting a year-over-year increase of approximately 14%[29] - The adjusted operating income (tax-effected) for the nine months ended June 28, 2025, was $182,678 million, compared to $151,227 million in the same period of 2024, marking a year-over-year increase of approximately 21%[29] Guidance and Future Outlook - The company initiated fiscal fourth quarter 2025 revenue guidance of $1.025 billion to $1.065 billion, with GAAP diluted EPS guidance of $1.57 to $1.72[5] - Plexus secured 41 manufacturing programs during the quarter, representing $250 million in annualized revenue when fully ramped into production[6] Cash Flow and Capital Management - Free cash flow for the third quarter was $13.2 million, contributing to year-to-date free cash flow of $56.8 million[6] - The cash cycle for the third quarter was 69 days, consistent with expectations and one day higher than the previous quarter[7] - Return on invested capital (ROIC) for the third quarter was 14.1%, exceeding the weighted average cost of capital by 520 basis points[7] - The company's ROIC for the nine months ended June 28, 2025, was 14.1%, up from 10.4% in the same period of the previous year, indicating improved capital efficiency[29] - The average invested capital as of June 28, 2025, was $1,364,073 million, an increase from $1,262,612 million in the previous year, showing a growth of about 8%[29] - Cash and cash equivalents as of June 28, 2025, were $237,567 million, a decrease from $317,161 million in the previous year, reflecting a tighter liquidity position[29] Shareholder Returns - Plexus has initiated a new $100 million share repurchase program, following the completion of a previous $50 million program[6] Sector Performance - Revenue from the Aerospace/Defense sector was $183 million, while Healthcare/Life Sciences and Industrial sectors generated $420 million and $415 million, respectively[10] - The top 10 customers comprised 48% of revenue during the third quarter, down three percentage points from the previous quarter[9] Balance Sheet Highlights - Total current assets decreased to $2,395,068 from $2,477,150 as of September 28, 2024, a decline of 3.3%[22] - Total liabilities decreased to $1,686,548 from $1,828,996, a reduction of 7.8%[22] - Shareholders' equity increased to $1,419,085 from $1,324,825, an increase of 7.1%[22] Tax and Economic Performance - The adjusted effective tax rate decreased to 11% for the nine months ended June 28, 2025, down from 16% in the same period of 2024, which positively impacted net income[29] - Economic return for the nine months ended June 28, 2025, was 5.2%, compared to 2.2% in the same period of the previous year, indicating a significant improvement in economic performance[29] Restructuring Charges - The company reported a restructuring and other charges of $4,683 million for the nine months ended June 28, 2025, which is consistent with the previous period[29]

Core Viewpoint - Plexus Corp. is set to release its fiscal third quarter 2025 results on July 23, 2025, and will host a conference call on July 24, 2025, to discuss these results [1]. Company Information - Plexus Corp. has been in operation since 1979, focusing on partnering with companies to create products that contribute to a better world [3]. - The company employs over 20,000 individuals and specializes in providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing, and Sustaining Services [3]. - Plexus is recognized as a global leader in serving customers in industries characterized by highly complex products and demanding regulatory environments [3]. Event Details - The fiscal 2025 Q3 earnings conference call and webcast will take place on July 24, 2025, at 8:30 a.m. Eastern Time [4]. - Participants are encouraged to join the live webcast available in the investor relations section of the Plexus website [4].

Core Insights - Plexus Corp. released its fiscal 2024 Sustainability Report, emphasizing its commitment to sustainability and responsible innovation as integral to its values [1][2] - The report highlights significant achievements in enhancing employee growth, strengthening partnerships, and reducing environmental impact [2][6] Sustainability Achievements - Achieved a 6.4% absolute reduction in Scope 1 & 2 combined emissions compared to the fiscal 2023 baseline [6] - Delivered a 13.7% global reduction in waste to landfill intensity year-over-year [6] - Contributed over $1 million globally through the Plexus Community Foundation [6] - Recorded over 20,000 paid volunteer hours in local communities, marking a 10.7% increase year-over-year [6] - Assessed over 50% of its global supply chain spend based on sustainability criteria [6] Company Overview - Plexus has been partnering with companies since 1979 to create products that contribute to a better world, employing over 20,000 individuals [4] - The company specializes in providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing, and Sustaining Services [4]